NCT06630234 - A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions

Gastrointestinal Stromal Tumor (GIST)

Interventions

DRUG

DCC-3009

Administered orally

Trial Locations (10)

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

Mayo Clinic Florida, Jacksonville

RECRUITING

University of Miami - Sylvester Comprehensive Cancer Center, Miami

RECRUITING

Vanderbilt University-Ingram Cancer Center, Nashville

RECRUITING

START Midwest, Grand Rapids

RECRUITING

Mayo Clinic Rochester, Rochester

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

RECRUITING

HonorHealth, Scottsdale

RECRUITING

UC San Diego Moores Cancer Center, La Jolla

RECRUITING

Dana Farber Cancer Institute, Boston